Charles Mxxx –DCEM2 Toulouse Purpan Medical School 01/26 ... · Charles Mxxx –DCEM2 Toulouse...
Transcript of Charles Mxxx –DCEM2 Toulouse Purpan Medical School 01/26 ... · Charles Mxxx –DCEM2 Toulouse...
Charles Mxxx – DCEM2
Toulouse Purpan Medical School
01/26/2012
ECN Item 162
� Definition � Pathophysiology
� Clinical signs and symptoms
� Biology and Diagnosis
� Different types of AL
� Prognosis and Treatment
� Malignant Hemopathy: cancer
- Accumulation of blasts in the bone marrow
- Affects the production of normal blood cell (↘)
- Rapid evolution without TTT
� ≠ Chronic leukemia: - ↗ production
- slow evolution
� Rare disease: 4-5/100,000/year
� 2 main types
- Acute Myelogenous Leukemia (age++)
- Acute Lymphoblastic Leukemia: 1/3 of children K
+ several subtypes
http://www.articlesbeach.com/wp-content/uploads/2011/08/Sub-Type-of-Leukemia.jpg
� Mutagenic event � Successive mutations (many genes involved) � Leukemic phenotype
� Maturational arrest of bone marrow cells
� Early stages of development
= Clonal proliferation of immature cells
1. Accumulation of immature cells
in the bone marrow (+/-other organs)
2. Decreased production of normal blood cells
� Etiological Factors: - Mostly unknown
- Hematological disorder: myelodisplastic syndrome ++
- Chemotherapeutic agents: alkylating agents, topoisomerase II inhibitors
- Genetic factors: Trisomy 21, Fanconi disease, Li-Fraumeni syndrom, …
- Environmental exposures: ionizing radiations, benzene
http://www.articlesbeach.com/disease-illness/leukemia/acute-leukemias-etiology-clinical-features-laboratory-features-treatment/
� Tumoral syndrome: infiltration by leukemic cells
- Adenopathies
- Hepato-Splenomegaly- Visceral localisations: gums, bones, skin, testicles, ... - If WBC>100,000 cells/uL
= leukostasis = clump of leukocytes in pulmonary or brain capillaries
(ARD, coma, convulsions � emergency)
� Signs of medullar insufficiency- Anemic syndrome (asthenia, paleness, dizziness, …)
- Haemorrhagic syndrome (bleeding gums, ecchymoses)- +/- Infectious signs (fever++): located infection �
septicemia
•VARIABLE• UNSPECIFIC: ORIENTATION ++
http://www.leucemie-espoir.org/spip.php?article72
http://www.lookfordiagnosis.com/mesh_info.php
� Diagnosis: Based on biological results
� Complete Blood Count: - Aregenerative Anemia ++ - Thrombocytopenia- Neutropenia- Leukocytopenia vs. Hyperleukocytosis- +/- Blasts (myeloid or lymphoid)
� Bone marrow Aspiration: - Rich marrow- >20% Blasts- ↘ normal cells
� Complementary studies: - morphological studies - immunophenotyping ESSENTIAL TO - cytochemistry investigations (MPO reaction) CLASSIFY- cytogenetic studies: karyotype (prognosis++) THE - molecular evaluation of BW DISEASE
http://www.picturesdepot.com/medical/12057/acute+lymphoblastic+leukemia.html
FURTHER INVESTIGATIONS
o Clotting studies: Disseminated Intravascular Coagulation (AML3++)
- ↗ Prothrombin time
- ↗fibrinogen level
- fibrin split product
o Blood electrolytes profile: ↗ LDH, ↗Uric acid,
↗K+, ↘ Ca++ (tumor lysis syndrome)
o Lumbar Puncture: systematic (brain localization ?)
o Chest X-ray: pneumopathy, leukostasis
o +/- Fever: Blood culture, urine culture
o +/- Pre-transfusion procedures = blood group, serologies (HIV, HBV, HCV, CMV)
http://www.santetropicale.com/club/pdf/1206/5312_10.pdf
Acute Myeloid Leukemia
(AML)
Acute Lymphoblastic Leukemia
(ALL)
Classification FAB: morphology, degree of
differenciation of blasts (LAM 0 to LAM 7 )
OMS: Clinical, morphological &
cytogenetic characteristics
preB-cell ALL (>85%)
preT-cell ALL (10-15%)
Cytology Myeloblasts: - big size
- granulations
- Auer rods
Lymphoblasts: - small size
- shape: rounded cells
- reduced cytoplasm
Cytochemistry MPO positive MPO negative
Immunophenotyping Myeloid markers (CD13, CD33,…) Lymphoid markers
http://med2.univ-angers.fr/discipline/lab_hema/Archives_ABP/html/2009%2013.htmhttp://www.leucemie-espoir.org/spip.php?article149
Gravity Signs Symptomatic Treatment
Thrombocytopenia / Bleedings � Platelets Transfusions
Septic shock / Fever � ATB +/- Intensive care
Agranulocytosis + Fever � IV ATB with broad spectrum
Leukostasis (Oncologic ER) �Chemotherapy/ Leukopheresis
Tumor lysis syndrome �Hydratation, Alcalinisation, …
Anemia (Hb<8g/dL) � Red blood cells Transfusions
� Objectives of Treatment: - Complete Remission (<5% blasts in BW, normalization of CBC)
- Maintain the complete Remission
- Avoid relapses
1) Induction therapy: INTENSIVE CHEMOTHERAPY = ↘ of leukemic cells
- ≈ 1 month
- AML: anthracyclins + arabinosylcytosine
- ALL: anthracyclins, vincristin, prednisone, cyclophosphamide.
� Induced aplasia
2) Consolidation therapy: Maintain complete remission
- chemotherapy (several months)
+/- allogeneic HSCT: efficient to avoid relapses � ALL: children, only if bad prognosis
� AML: age <60 (sepsis, toxicity++)
+/- autologous HSCT
*HSCT = ↘ of relapse rate, ↗ of 6-year survival rate in patients younger than 50
Some cases: supportive chemotherapy (2 years): children ALL if no HSCT, APL
3) Supportive care: Heavy treatment
- « Hematologic resuscitation »: � transfusions support
� anti-infectious care (isolation, ATB)
- nutritional supplements
- staff: experience ++ in treatment of leukemias
4) New treatments:
Advanced knowledges on the pathophysiology of AL = New treatment perspectives
- Azacitidine (VIDAZA): DNA hypomethylation
* no AMM in this indication: trial in process
- Monoclonal Antibodies: new targets
- Histone Deacetylase Inhibitors: « Ras » inactivation = cell growth
arrest
http://fr.dreamstime.com/image-stock-transfusion-sanguine-image
http://www.medic-abc.com.mx/hoja_vidaza.html
Accumulation of blasts in the bone marrow
http://defi-anthony.org/default.aspx
↗ production of normal blood cells
CLINIC: ONLY ORIENTATION
Tumoral syndrom Medullar Insuffisiency
Bone Marrow Aspiration: > 20% blasts CBC results: always abnormal
Heavy Treatment: Etiological, treatment of gravity signs, supportive care
htt
p:/
/de
fi-a
nth
on
y.o
rg/d
efa
ult
.asp
x
� http://emedicine.medscape.com
� http://www.fascicules.fr/data/consulter/hematologie-polycopie-leucemie-
aigue.pdf
� http://www-sante.ujf-grenoble.fr
� http://www.medecine.ups-tlse.fr/dcem3/
� http://theoncologist.alphamedpress.org/content/10/8/565.abstract
� Livre du Collège National des Enseignants d’Hématologie
� Livre du Collège National des Enseignants en Médecine Interne (éd.Ellipses)
� Dictionnaire Médical, 5ème édition (éd. MASSON)
� http://www.leucemie-espoir.org
� http://sfh.hematologie.net